MTA2 and Alzheimer disease: Surprisingly, quantitative analyses of MAO-B-immunoreactive area fraction revealed that CBD, PiD, and FTLD-TDP donors exhibit an even higher MAO-B expression than donors with high ADNC burden and much higher than CTRL donors (Not AD/Low ADNC burden).